Title: 2017 ACVIM Forum Research Abstract Program Document date: 2017_6_15
ID: ri2w5iby_114
Snippet: Time to CHF was not significantly different between groups (all P > 0.2). Time to cardiac death was longer with benazepril-vsmethyldigoxin (P = 0.034), pimobendan-vs-methyldigoxin (P = 0.007), benazepril-vs-pimobendan+benazepril (P = 0.005), pimobendan-vs-pimobendan+benazepril (P = 0.004), and methyldigoxin+benazepril-vs-pimobendan+benazepril (P = 0.027), respectively. Survival from all-cause mortality was significantly longer for pimobendan-vs-m.....
Document: Time to CHF was not significantly different between groups (all P > 0.2). Time to cardiac death was longer with benazepril-vsmethyldigoxin (P = 0.034), pimobendan-vs-methyldigoxin (P = 0.007), benazepril-vs-pimobendan+benazepril (P = 0.005), pimobendan-vs-pimobendan+benazepril (P = 0.004), and methyldigoxin+benazepril-vs-pimobendan+benazepril (P = 0.027), respectively. Survival from all-cause mortality was significantly longer for pimobendan-vs-methyldigoxin (0.029) and benazeprilvs-pimobendan+benazepril, respectively (P = 0.045). Time to cardiac death was longest for 'responders' (median-4.8 years) vs (median-2.9 years) (P = 002); time to all-cause death was not different (P = 0.067).
Search related documents:
Co phrase search for related documents- cardiac death and cause death time: 1
- cardiac death and cause mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- cardiac death and cause mortality survival: 1
- cardiac death time and cause death: 1
- cardiac death time and cause death time: 1
- cause mortality and responder year: 1
Co phrase search for related documents, hyperlinks ordered by date